Search News
| 12.36 Delayed Data As of 4:00pm ET |  -0.34 / -2.68%Today’s Change | 7.95 Today|||52-Week Range 24.02 | +25.99% Year-to-Date |
| Previous close | 12.70 |
| Today’s open | 12.65 |
| Day’s range | 12.32 - 12.84 |
| Volume | 36,732 |
| Average volume (3 months) | 173,009 |
| Market cap | $288.7M |
| Earnings growth (last year) | +17.74% |
| Earnings growth (this year) | +8.99% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -97.44% |
| P/E ratio | NM |
| Price/Sales | 967.97 |
| Price/Book | 5.56 |
| Today’s change | Today’s % change | |
|---|---|---|
| MRSNMersana Therapeutics... | +0.73 | +6.00% |
| NSTGNanoString Technolog... | +0.54 | +3.86% |
| BLCMBellicum Pharmaceuti... | +0.11 | +1.69% |
| GERNGeron Corp | +0.02 | +0.51% |
| Next reporting date | November 5, 2018 |
| EPS forecast (this quarter) | -$0.71 |
| Annual revenue (last year) | $207.0K |
| Annual profit (last year) | -$65.3M |
| Net profit margin | -31,556.04% |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Werner Cautreels |
COO, Senior Vice President-Research & Development Lloyd Johnston |
Corporate headquarters Watertown, Massachusetts |
